MedPath

A study on the effects of drug (2% diltiazem) and surgical procedure (lateral internal sphincterotomy) for chronic anal fissure

Not Applicable
Conditions
Health Condition 1: - Health Condition 2: O- Medical and Surgical
Registration Number
CTRI/2022/02/040119
Lead Sponsor
Dr Nitin Sherkar
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

a)ALL PATIENTS WHO WILL PRESENT IN SURGICAL OUT-PATIENT DEPARTMENT WITH COMPLAINTS OF PAINFUL PASSAGE OF STOOL, WITH OR WITHOUT BLEEDING OF MORE THAN 6 WEEKS DURATION, DIAGNOSED TO BE HAVING CHRONIC ANAL FISSURE BASED ON THE HISTORY AND ON CLINICAL EXAMINATION.

b)ALL PREVIOUSLY DIAGNOSED CASES OF ACUTE ANAL FISSURE WHO ARE TAKING STOOL SOFTENER AND MEDICATIONS FOR MORE THAN 6 WEEKS

Exclusion Criteria

PATIENTS OF CHRONIC ANAL FISSURE ASSOCIATED WITH

a)TUBERCULOSIS

b)HAEMORRHOIDS

c)ANORECTAL ABSCESSES

d)ANAL MALIGNANCIES

e)IMMUNOCOMPROMISED PATIENTS

f) PREVIOUS HISTORY OF FAECAL INCONTINENCE OR ANAL STENOSIS

g) PATIENTS WHO HAVE UNDERGONE PREVIOUS ANAL SURGERIES

h)PATIENTS WITH HISTORY OF BLEEDING

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath